MarketResearchReports.com: The Ophthalmology Therapeutics Market for Dry Eye Syndrome (DES) Is Expected to Reach $6.1 Billion by 2019
December 31, 2013 at 11:30 AM EST
Lewes, DE -- (SBWIRE) -- 12/31/2013 -- The ophthalmology therapeutics market for Dry Eye Syndrome (DES) and glaucoma in the eight major countries - the US, the UK, France, Germany, Italy, Spain, Canada and Japan - is expected to increase moderately, climbing from $3.7 billion in 2012 to $6.1 billion by 2019, at a Compound Annual Growth Rate (CAGR) of 7.6%.
